DrugPatentWatch Database PreviewSee Plans and Pricing
« Back to Dashboard
Eniluracil is an investigational drug.
There have been 8 clinical trials for Eniluracil. The most recent clinical trial was a Phase 3 trial, which was initiated on April 1st 1999.
The most common disease conditions in clinical trials are Colorectal Neoplasms, Colonic Neoplasms, and Carcinoma. The leading clinical trial sponsors are National Cancer Institute (NCI), Adherex Technologies, Inc., and Investigator initiated study.
Recent Clinical Trials for Eniluracil
|Study of Eniluracil + 5-Fluorouracil (5-FU) + Leucovorin Versus Capecitabine in Metastatic Breast Cancer||Adherex Technologies, Inc.||Phase 2|
|Eniluracil Hand Foot Syndrome||Investigator initiated study||Phase 1|
|Eniluracil Hand Foot Syndrome||West Virginia University||Phase 1|